Live Breaking News & Updates on Tsha

Stay informed with the latest breaking news from Tsha on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Tsha and stay connected to the pulse of your community

Taysha Gene Therapies (NASDAQ:TSHA) Shares Gap Up to $2.68

Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Get Free Report) shares gapped up prior to trading on Tuesday . The stock had previously closed at $2.68, but opened at $2.95. Taysha Gene Therapies shares last traded at $3.12, with a volume of 1,228,318 shares trading hands. Analyst Ratings Changes A number of equities analysts have recently […]

Acuta-capital-partners , Cantor-fitzgerald , Needham-company , Nasdaq , Vanguard-group-inc , Canaccord-genuity-group , Taysha-gene-therapies-company-profile , Taysha-gene-therapies-inc , Taysha-gene-therapies , Get-free-report , Gene-therapies

45,000 Shares in Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Acquired by Williams & Novak LLC

Williams & Novak LLC acquired a new position in shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Free Report) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 45,000 shares of the company’s stock, valued at approximately $80,000. Several other hedge funds and other institutional […]

Switzerland , Swiss , Piper-sandler , Cantor-fitzgerald , Renaissance-technologies , Nasdaq , Jpmorgan-chase-co , Needham-company , Swiss-national-bank , Securities-exchange-commission , Taysha-gene-therapies-inc , Williams-novak

Taysha Gene Therapies (NASDAQ:TSHA) Stock Rating Reaffirmed by Canaccord Genuity Group

Canaccord Genuity Group reaffirmed their buy rating on shares of Taysha Gene Therapies (NASDAQ:TSHA – Free Report) in a report published on Thursday morning, Benzinga reports. Canaccord Genuity Group currently has a $7.00 price objective on the stock. TSHA has been the topic of a number of other research reports. Cantor Fitzgerald reissued an overweight […]

Victory-capital-management-inc , Canaccord-genuity-group , Capital-management , Taysha-gene-therapies-inc , Maven-securities , Capital-investment-advisors , Howard-capital-management-inc , Needham-company , Cantor-fitzgerald , Taysha-gene-therapies , Free-report

'Melusi from Gomora': Who is Zolisa Xaluva's girlfriend?

Award-winning actor Zolisa Xaluva has kept his private life under wraps, leaving many to guess even about his girlfriend.

South-africa , South-african , Zolisa-xaluva , Tsha , Lwazi-mboweni , Mzansi-magic ,

Taysha Gene Therapies (NASDAQ:TSHA) vs. Editas Medicine (NASDAQ:EDIT) Head-To-Head Analysis

Taysha Gene Therapies (NASDAQ:TSHA – Get Free Report) and Editas Medicine (NASDAQ:EDIT – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, risk, analyst recommendations, profitability, dividends, earnings and valuation. Insider & Institutional Ownership 25.9% of […]

University-of-texas-southwestern-medical-center , Texas , United-states , Cambridge , Cambridgeshire , United-kingdom , Massachusetts , Dallas , Juno-therapeutics-inc , Allergan-pharmaceuticals-international , Editas-medicine-inc

Taysha Gene Therapies (NASDAQ:TSHA) Trading 11.9% Higher

Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Get Free Report)’s share price was up 11.9% during mid-day trading on Thursday . The stock traded as high as $2.85 and last traded at $2.82. Approximately 326,018 shares traded hands during mid-day trading, a decline of 82% from the average daily volume of 1,794,341 shares. The stock had […]

Switzerland , Swiss , Swiss-national-bank , Nasdaq , Taysha-gene-therapies-inc , Cantor-fitzgerald , Jpmorgan-chase-co , Renaissance-technologies , Vanguard-group-inc , Taysha-gene-therapies , Get-free-report

EAM Investors LLC Purchases Shares of 335,390 Taysha Gene Therapies, Inc. (NASDAQ:TSHA)

EAM Investors LLC purchased a new position in Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Free Report) in the third quarter, Holdings Channel.com reports. The fund purchased 335,390 shares of the company’s stock, valued at approximately $1,060,000. Other large investors have also added to or reduced their stakes in the company. Swiss National Bank lifted its […]

Switzerland , Swiss , Nasdaq , Jpmorgan-chase-co , Cantor-fitzgerald , Vanguard-group-inc , Taysha-gene-therapies-inc , Renaissance-technologies , Eam-investors , Holdings-channel , Swiss-national-bank

EAM Investors LLC Acquires New Position in Taysha Gene Therapies, Inc. (NASDAQ:TSHA)

EAM Investors LLC bought a new stake in Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 335,390 shares of the company’s stock, valued at approximately $1,060,000. EAM Investors LLC owned about 0.18% […]

Taysha-gene-therapies-inc , Lee-financial-co , Eam-investors , Exchange-commission , Citigroup-inc , Nasdaq , Cantor-fitzgerald , Kovitz-investment-group-partners , Taysha-gene-therapies , Free-report , Investment-group-partners

Brokerages Set Taysha Gene Therapies, Inc. (NASDAQ:TSHA) PT at $5.38

Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Get Free Report) has received an average rating of “Moderate Buy” from the ten research firms that are currently covering the firm, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 1 […]

Chicago , Illinois , United-states , Paulb-manning , Cantor-fitzgerald , Canaccord-genuity-group , Taysha-gene-therapies-inc , Taysha-gene-therapies-company-profile , Chicago-partners-investment-group , Nasdaq , Quantum-private-wealth

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

Shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the ten brokerages that are currently covering the firm, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average […]

Chicago , Illinois , United-states , Paulb-manning , Quantum-private-wealth , Securities-exchange-commission , Nasdaq , Chicago-partners-investment-group , Dynamic-advisor-solutions , Citigroup-inc , Canaccord-genuity-group